Aethlon Medical Inc at HC Wainwright Investment Conference - New York Transcript
Hi, everyone. Welcome to the second day of the H.C. Wainwright 25th Annual Global Investment Conference. My name is Vernon Bernardino, a senior analyst. With us today, our next company is Aethlon Medical, which I think would be very interested in because with the Hemopurifier, I think it's a novel approach to treating diseases, particularly in the COVID space. There's a real opportunity there.
I don't think anyone would have thought of, but they've established a track record with other viruses. And I think you'll be interested in what they had to say there. But also in oncology in that space, something called (technical difficulty).
With us today is the Chief Medical Officer, Steven LaRosa; and the Chief Financial Officer, Jim Frakes. Take it away, Jim.
Thank you, Vernon. And thanks, everybody, for attending our presentation. Forward-looking statement, you can look at that your convenience. Our presentation will be on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |